Last edition
News about
The 8th edition of PharmaLytica Expo opened its doors to industry professionals at the Bombay Exhibition Centre, Mumbai from 1st June 2022 to 3rd June 2022.
More than 300 brands exhibhiting at Pharmalytica India 2022
The 8th edition of the PharmaLytica Expo, the top global pharma trade show and conference, is being organised by Informa Markets in India, the leading B2B exhibitions organiser. The three-day exhibition will take place at the Bombay Exhibition Centre in Mumbai from June 1 to 3, 2022.
Rs 100 crore invested by Chemo Pharma to expand operations in Telangana
Chemo Pharma, based in Spain, has announced a '100 crore investment in Hyderabad for the establishment of its second-line production of pharmaceutical dosage forms.
Gentle and energy-efficient pneumatic conveying systems
Pneumatic dense phase conveying is among the gentlest solutions and is often the only technology suited to transport large product volumes efficiently and hygienically without demixing. It enables low-abrasion transport as well as complete emptying of the conveyor pipe. Additionally, it reduces maintenance costs and energy consumption.
Activated Rispharm, will be introduced at Pharmapack 2022
The first-to-market multidose antimicrobial dropper to help prevent eye microbial infections for patients
Advantage eClinical provides a fully integrated suite of data management applications.
Myovant Sciences and Accord Healthcare to commercialize ORGOVYX in Europe
“We are proud to launch ORGOVYX in Europe, as an addition to our specialty brand offerings,” said Binish Chudgar, Managing Director of Accord.
BioNTech 2nd phase of Covid 19 trials completed
The vaccine, based on messenger RNA (mRNA) technology, is one of the most widely used worldwide against COVID, but has yet to receive an approval in China, which has relied only on domestically-developed vaccine
Drug delivery push deal continued with Stevanato
Stevanato has added another drug delivery technology to its portfolio, teaming up with Owen Mumford to provide customers with a two-step, single-use auto-injector that automatically adapts to a range of fill volumes.
US FDA approval for Incyte's Olumiant
Eli Lilly and Company and Incyte announced the US Food and Drug Administration (FDA) has approved Olumiant (baricitinib) for the treatment of Covid-19 in hospitalized adults requiring supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO) with a recommended dose of 4-mg once daily for 14 days.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy